J Endocrinol Metab
Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc
Journal website http://www.jofem.org

Case Report

Volume 9, Number 3, June 2019, pages 77-78

Oscillating Hypothyroidism and Hyperthyroidism: A Rare Autoimmune Syndrome

Gabriel Melkia, b, FNU Komala, Linda Lahama, Gres Karima, Vinod Kumara, Sushant Nanavatia, Mourad Ismaila

aDepartment of Internal Medicine, St. Joseph’s University Medical Center, Paterson, NJ 07503, USA
bCorresponding Author: Gabriel Melki, Department of Internal Medicine, St. Joseph’s University Medical Center, Paterson, NJ 07503, USA

Manuscript submitted May 28, 2019, accepted June 8, 2019
Short title: Oscillating Hypothyroidism and Hyperthyroidism
doi: https://doi.org/10.14740/jem583


Graves’ disease is an autoimmune thyroid disorder with overproduction of thyroid hormones secondary to the production of thyroid-stimulating hormone receptor (TSH-R) stimulating antibodies (TSAbs). It is very common for Graves’ disease patients to convert to a hypothyroid state especially in end-stage Graves’ disease or after iodine ablation. These patients require lifelong thyroxin replacement therapy. In this case report, we describe a rare phenomenon known as “oscillating hypo- and hyperthyroidism”. In this rare entity of autoimmune endocrine disorder patients with hypothyroidism spontaneously convert to Graves’ disease.

Keywords: Graves’ disease; Autoimmune; Oscillating hypothyroidism and hyperthyroidism; Oscillating hypo- and hyperthyroidism


Autoimmune thyroid diseases tend to move thyroid hormones in one direction. Graves’ disease is a well known cause for hyperthyroidism. While transforming from Graves’ hyperthyroidism into hypothyroidism is not uncommon, having both conditions simultaneously forms a unique combination and a challenge to medical management. We present a case of a 37-year-old woman who had oscillating hypothyroidism and hyperthyroidism, and a surgical ablation of the gland was recommended as definitive treatment.

Case Report▴Top 

A 37-year-old woman with the PMH of type 1 diabetes, Hashimoto thyroiditis being treated with levothyroxine and autoimmune pancreatitis came to the emergency department (ED) with complaints of palpitations, tremors, and anxiety. The patient’s vitals were: heart rate (HR): 110, temperature: 100 F, respiratory rate (RR): 18/min, blood pressure (BP): 160/90. Physical exam was positive for exophthalmos and pretibial myxedema. Patient labs revealed: high free T3 of 4.83 pg/mL and high free T4 of 2.18 ng/dL and undetectable thyroid-stimulating hormone (TSH) of 0.015 uIU/mL (Supplementary 1). Thyroid ultrasound revealed diffuse enlargement of the thyroid gland and thyroid isotope scan revealed diffusely increased uptake, suggestive of Graves’ disease and therefore TSH receptor (TSH-R) stimulating antibodies (TSAbs) were ordered which were positive.

Prior records of this patient revealed that the patient’s TSH was high (57.143 uIU/mL), free T3 (2.12 pg/mL) and free T4 (0.42 ng/dL) were low and patient was being treated with levothyroxine, but based on new signs and symptoms and new investigation the patient was diagnosed with Graves’ disease. Patient was offered various treatment options like thyroid ablation and surgery; however she refused any kind of intervention and was treated with methimazole.

After a few months, the patient developed signs and symptoms of hypothyroidism. Labs were drawn and revealed that the TSH was elevated at 62.993 uIU/mL, free T3 and free T4 were low at 2.01 pg/mL and 0.7 ng/dL respectively and TSH-R blocking antibodies (TBAbs) were sent and were positive. These symptoms and laboratory data were suspicious of hypothyroidism. The patient’s change from hyper- to hypothyroidism prompted us to diagnose the patient with oscillating hypothyroidism and hyperthyroidism.


Oscillating hypothyroidism and hyperthyroidism is an autoimmune entity due to the production of two types of thyrotropin receptor (TSH-R) autoantibodies found in immune disorders of the thyroid: TSAb and TBAb. TSAb is responsible for overactive thyroid gland causing Graves’s disease, while TBAb causes hypothyroidism by blocking endogenous TSH.

In one study by Takeda et al [1], they described that both types of TSH-R antibodies can coexist in one patient and that the thyroid function and clinical picture may change according to the balance of the type antibodies seen in the patient’s system.

In another study by McLachlan et al [2], they concluded that the balance between TBAb and TSAb can be shifted because of treatment with thyroid hormone replacement therapy or antithyroid treatment. Both therapies can alter the level of thyroid antibodies and can easily swing balance from hypo- to hyperthyroidism and vice versa.

This disease is difficult to treat as treatment of hypothyroidism can lead to overactive hyperthyroid. A block and replace regimen may improve stability over the short to intermediate term, but this is not a definitive therapy and requires long-term close monitoring. Definitive therapy includes both thyroidectomy and radioactive iodine, which has the disadvantage in that it can only be performed in the hyperthyroid phase [3].

The patient was educated about all available treatment options; however, the patient refused thyroidectomy and opted for treatment with antithyroid medications. The patient was specifically treated with methimazole. Without definitive treatment such as surgery or thyroid ablation, management can be challenging and close monitoring of the patient along with regular thyroid function test will be required for ongoing follow-up [3].


Physicians encounter cases of both hypothyroidism and hyperthyroidism throughout their careers; however they should always remain attentive to both the patient’s symptoms and laboratory values as cases of oscillating hypo- and hyperthyroidism are rare but need strict rigorous monitoring. Physicians must be careful in treating these cases, as patients can easily switch between hypo- and hyperthyroid states. The learning points include: 1) Patients with these autoimmune phenomena should be monitored with TSAb and TBAb along with thyroid function tests; and 2) Definitive therapy for oscillating hypothyroid and hyperthyroid is thyroidectomy (during any state of disease) or radioactive iodine ablation, while the patient is in the hyperthyroid state.


We thank Dr. Patrick Michael, Program Director of the Internal Medicine Residency for his continuous support and guidance.

Financial Disclosure

No funding was provided to any of the authors.

Conflict of Interest

The authors declare that they have no conflict of interest.

Informed Consent

Informed consent was obtained from the patient for this case report.

Author Contributions

All authors contributed to the revision and approval of the manuscript.

  1. Takeda K, Takamatsu J, Kasagi K, Sakane S, Ikegami Y, Isotani H, Majima T, et al. Development of hyperthyroidism following primary hypothyroidism: a case report with changes in thyroid-related antibodies. Clin Endocrinol (Oxf). 1988;28(4):341-344.
  2. McLachlan SM, Rapoport B. Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid. 2013;23(1):14-24.
    doi pubmed
  3. Wong M, Inder WJ. Alternating hyperthyroidism and hypothyroidism in Graves' disease. Clin Case Rep. 2018;6(9):1684-1688.
    doi pubmed

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Journal of Endocrinology and Metabolism is published by Elmer Press Inc.


Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics


World Journal of Oncology

Gastroenterology Research

Journal of Hematology


Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity


Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research


Journal of Neurology Research

International Journal of Clinical Pediatrics



Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.